Member Exclusive INTERVIEW

#TalkingRegMed episode 6: Brexit with Matthew Durdy, Cell and Gene Therapy Catapult

In this episode of #TalkingRegMed, Matthew Durdy, Chief Business Officer, Cell and Gene Therapy Catapult, explains the effect of Brexit on cell therapy development in the UK.

Go to the profile of RegMedNet
Mar 13, 2018

Please sign in or register for FREE

No comments yet.